We found 10 episodes of Oncology Today with Dr Neil Love with the tag “research to practice”.
-
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
April 3rd, 2024 | Season 1 | 1 hr 14 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on early research and available data with B7-H3-targeted antibody-drug conjugates with Dr Manish Patel, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
March 27th, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on clinical data from the past year on the management of prostate cancer with Drs Andrew Armstrong and Maha Hussain, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
March 26th, 2024 | Season 1 | 1 hr 13 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of lymphoma with Dr Andrew M Evens and Dr Sonali M Smith, moderated by Dr Neil Love. Produced by Research To Practice.
-
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
March 25th, 2024 | Season 1 | 1 hr 19 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy.
-
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
March 21st, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of hepatobiliary cancers with Dr Robin K (Katie) Kelley and Dr Mark Yarchoan, moderated by Dr Neil Love. Produced by Research To Practice.
-
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
March 19th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the role of approved and investigational antibody drug conjugates for non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
March 15th, 2024 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of HER2-positive and triple-negative breast cancer with Dr Ian E Krop and Dr Priyanka Sharma, moderated by Dr Neil Love. Produced by Research To Practice.
-
Virtual Case Library: Metastatic Urothelial Bladder Cancer
March 13th, 2024 | Season 1 | 2 hrs 8 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion of patient cases and relevant recent research on metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
March 11th, 2024 | Season 1 | 37 mins 32 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on available and investigational oral SERDs in the management of ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
March 8th, 2024 | Season 1 | 1 hr 4 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on optimal management approaches for myelofibrosis with Dr Stephen T Oh, moderated by Dr Neil Love. Produced by Research To Practice.